Advertisement
U.S. Markets closed

Neola Medical AB (publ) (NEOLA.ST)

Stockholm - Stockholm Real Time Price. Currency in SEK
2.4400-0.2000 (-7.58%)
At close: 12:35PM CEST
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
0
0
0
625
31
-
Cost of Revenue
-9,033
-8,019
-8,017
-8,427
-1,506
-
Gross Profit
9,033
8,019
8,017
9,052
1,537
-
Operating Expense
19,298
17,645
18,402
15,705
8,253
-
Operating Income
-10,265
-9,626
-10,385
-6,653
-6,716
-
Net Non Operating Interest Income Expense
788
612
33
0
-1
-
Pretax Income
-9,471
-9,010
-10,353
-6,653
-6,717
-
Tax Provision
0
0
0
0
0
-
Net Income Common Stockholders
-9,471
-9,010
-10,353
-6,653
-6,717
-
Diluted NI Available to Com Stockholders
-9,471
-9,010
-10,353
-6,653
-6,717
-
Basic EPS
-0.19
-0.17
-0.40
-0.47
-0.71
-
Diluted EPS
-0.19
-0.17
-0.40
-0.47
-0.71
-
Basic Average Shares
52,048
55,766
26,071
14,014
9,522
-
Diluted Average Shares
55,686
55,766
26,071
14,014
9,522
-
Total Operating Income as Reported
-10,259
-9,621
-10,386
-6,653
-6,716
-
Total Expenses
10,265
9,626
10,385
7,278
6,747
-
Net Income from Continuing & Discontinued Operation
-9,471
-9,010
-10,353
-6,653
-6,717
-
Normalized Income
-9,471
-9,010
-10,353
-6,653
-6,717
-
Interest Income
-
-
-
-
0
0
Interest Expense
-
-
-
0
1
0
Net Interest Income
788
612
33
0
-1
-
EBIT
-10,265
-9,626
-10,385
-6,653
-6,716
-
EBITDA
-8,666
-8,033
-9,348
-6,638
-6,709
-
Reconciled Cost of Revenue
-9,033
-8,019
-8,017
-8,427
-1,506
-
Reconciled Depreciation
1,599
1,593
1,037
15
7
-
Net Income from Continuing Operation Net Minority Interest
-9,471
-9,010
-10,353
-6,653
-6,717
-
Total Unusual Items Excluding Goodwill
-
-
-
-
0
10
Total Unusual Items
-
-
-
-
0
10
Normalized EBITDA
-8,666
-8,033
-9,348
-6,638
-6,709
-
Tax Rate for Calcs
0
0
0
0
0
-
Tax Effect of Unusual Items
0
0
0
0
0
-